北京时间6月01日收盘,ZNTL市盈率为-33.13,ZNTL市值为17亿美元

ZNTL简介

ZentalisPharmaceuticals,Inc.isaclinical-stagebiopharmaceuticalcompanyfocusedondiscoveringanddevelopingsmallmoleculetherapeuticstargetingfundamentalbiologicalpathwaysofcancers.Ituseitshighlyefficientdrugdiscoveryengine,whichitrefertoasitsIntegratedDiscoveryEngine,toidentifytargetsanddevelopsmallmoleculenewchemicalentities,orNCEs,withpropertiesthatitbelievecouldresultinpotentiallydifferentiatedproductprofiles.Itsdiscoveryenginecombinesitsextensiveexperienceandcapabilitiesacrosscancerbiologyandmedicinalchemistry.